When should immunoelectrophoresis be ordered in the evaluation of a suspected monoclonal gammopathy or plasma‑cell disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immunoelectrophoresis in Monoclonal Gammopathy Evaluation

Immunoelectrophoresis has been largely replaced by immunofixation in modern clinical practice and should NOT be routinely ordered for the evaluation of suspected monoclonal gammopathy or plasma cell disorders.

Current Standard of Care

The International Myeloma Working Group consensus guidelines explicitly recommend serum protein electrophoresis with immunofixation as the standard diagnostic approach, not immunoelectrophoresis 1. The recommended laboratory workup includes:

  • Serum protein electrophoresis (SPEP) with immunofixation
  • Nephelometric quantification of serum immunoglobulins
  • 24-hour urine collection for electrophoresis and immunofixation
  • Serum free light chain measurement

Why Immunofixation Supersedes Immunoelectrophoresis

Immunofixation is the preferred confirmatory test because it:

  • Provides faster results
  • Offers superior sensitivity for detecting small M-proteins
  • Delivers clearer, more interpretable results
  • Has become the standardized method across laboratories

Historical literature from the 1980s-1990s described immunoelectrophoresis as "the method of choice" 2, 3, but this reflects outdated practice patterns. Modern guidelines from 2011 onward consistently specify immunofixation, not immunoelectrophoresis 1.

When to Order Confirmatory Testing

Order serum and urine immunofixation when:

  • Screening electrophoresis shows a suspicious monoclonal spike
  • Clinical suspicion exists for myeloma, macroglobulinemia, amyloidosis, or related disorders 2
  • Unexplained end-organ damage (renal insufficiency, neuropathy, bone lesions) is present
  • Screening shows elevated or suppressed immunoglobulin levels on nephelometry

Critical Diagnostic Algorithm

  1. Initial screening: SPEP and nephelometric immunoglobulin quantification
  2. If M-protein suspected: Add serum immunofixation to confirm presence and type (heavy and light chain)
  3. Urine evaluation: 24-hour urine collection with electrophoresis and immunofixation (even if no visible peak) 1
  4. Serum free light chains: Measure κ/λ ratio for risk stratification

Common Pitfalls to Avoid

  • Do not rely on random urine samples - 24-hour collection is mandatory for accurate quantification 1
  • Do not skip urine immunofixation even if urine electrophoresis shows no peak - light chains may be present without visible bands 1
  • Do not order immunoelectrophoresis when immunofixation is available - it provides no additional clinical value and delays diagnosis
  • Do not use immunoelectrophoresis results as equivocal - if results are unclear, order immunofixation instead 2

Emerging Technologies

Mass spectrometry (MALDI-TOF) is increasingly used for M-protein detection and monitoring, particularly for minimal residual disease assessment and in patients treated with therapeutic monoclonal antibodies that interfere with standard assays 4. However, immunofixation remains the current standard for initial diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.